Lexicon Pharmaceuticals
LXRX
#6174
Rank
ยฃ0.76 B
Marketcap
ยฃ1.73
Share price
-2.51%
Change (1 day)
89.99%
Change (1 year)

Earnings for Lexicon Pharmaceuticals (LXRX)

Earnings in 2025 (TTM): -ยฃ53.62 Million

According to Lexicon Pharmaceuticals 's latest financial reports the company's current earnings are ยฃ70.86 Million. In 2024 the company made an earning of -ยฃ0.15 Billion a decrease over its 2023 earnings that were of -ยฃ0.14 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lexicon Pharmaceuticals from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ53.62 Million-64.02%
2024 -ยฃ0.15 Billion13.15%
2023 -ยฃ0.14 Billion73.74%
2022 -ยฃ75.8 Million16.16%
2021 -ยฃ65.25 Million49.82%
2020 -ยฃ43.56 Million-147.19%
2019 ยฃ92.28 M-203.42%
2018 -ยฃ89.24 Million-15.31%
2017 -ยฃ0.11 Billion0.2%
2016 -ยฃ0.11 Billion2920.7%
2015 -ยฃ3.49 Million-95.33%
2014 -ยฃ74.63 Million-3.61%
2013 -ยฃ77.42 Million-5.52%
2012 -ยฃ81.95 Million-4.17%
2011 -ยฃ85.52 Million15.5%
2010 -ยฃ74.04 Million8.36%
2009 -ยฃ68.33 Million-4.81%
2008 -ยฃ71.78 Million28.79%
2007 -ยฃ55.73 Million35.71%
2006 -ยฃ41.07 Million52.91%
2005 -ยฃ26.86 Million-23.89%
2004 -ยฃ35.29 Million-24.19%
2003 -ยฃ46.54 Million-0.48%
2002 -ยฃ46.77 Million44.12%
2001 -ยฃ32.45 Million23.01%
2000 -ยฃ26.38 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Thermo Fisher Scientific
TMO
ยฃ5.51 B-10,922.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
ยฃ0.86 B-1,791.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
ยฃ3.83 B-7,619.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-ยฃ0.4 Billion 682.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
ยฃ0.12 B-338.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-ยฃ20.41 Million-59.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-ยฃ17.28 Million-66.11%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
ยฃ0.28 B-662.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-ยฃ7.06 Million-86.16%๐Ÿ‡บ๐Ÿ‡ธ USA